Mechanisms that regulate macrophage burden in atherosclerosis

Gwendalyn J Randolph1

  • 1From the Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO. grandolph@path.wustl.edu.

Insights

Mononuclear phagocytes (MPs) are key to atherosclerosis. Recent advances reveal mechanisms regulating MP accumulation and function in plaques, offering new avenues for disease reversal and prevention.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Atherosclerosis Research

Background:

  • Mononuclear phagocytes (MPs), including monocytes, macrophages, and dendritic cells, are central to atherosclerosis.
  • Historically, macrophage quantification in atherosclerotic lesions was limited.
  • Technological progress is enhancing the study of dynamic MP populations within plaques.

Purpose of the Study:

  • To review the evolution of atherosclerotic plaques focusing on changes in the MP compartment.
  • To discuss the roles of MP recruitment, proliferation, and retention in plaque development, progression, and regression.
  • To highlight current knowledge gaps and future research directions in MP biology and atherosclerosis.

Main Methods:

  • Review of recent literature and innovative methods for interrogating MP biology in atherosclerotic plaques.
  • Analysis of MP compartment dynamics from plaque initiation to regression.
  • Identification of mechanisms regulating MP accumulation and function.

Main Results:

  • Innovative methods have uncovered mechanisms governing MP accumulation and function in atherosclerotic plaques.
  • The roles of MP recruitment, proliferation, and retention vary across different stages of plaque evolution.
  • Key questions remain regarding cholesterol's role in macrophage accumulation and the interplay between innate and adaptive immunity in driving atherosclerosis.

Conclusions:

  • Understanding MP dynamics is crucial for comprehending atherosclerosis.
  • Future research should focus on distinguishing macrophage and dendritic cell roles and elucidating cholesterol-driven accumulation.
  • Investigating the innate-adaptive immune crosstalk in atherosclerosis is essential for developing therapeutic strategies.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
46.4K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
36
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
726
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.4K